The camelina plant, a source of cooking oil for ce
Waters Corporation (NYSE:WAT) today announced that
In a study in mice and human cells, Johns Hopkins
Dundee, UK, 14th January 2021 – Ubiquigent Limit
Drug firm Strides Pharma Science on Friday said it
A microplate or microtiter plate (spelled Microtit
E-Health stage Medlife on Tuesday said it has banded together with authorize labs to dispatch at-home testings for COVID-19 in select urban communities and plans to grow it going ahead.
The cost of a test is set at Rs 4,500 and will be directed by labs approved by the Indian Council of Medical Research (ICMR), Medlife said in an announcement.
It included that the tests will be directed utilizing ongoing PCR strategy.
At present, the COVID-19 testing administration is accessible in Mumbai, Delhi, Noida, Ghaziabad and Faridabad, it included.
Gurugram and Pune will be included quickly, the organization said.
Medlife has likewise propelled its e-counsel benefits and has empanelled 1,500 specialists across India for the equivalent, the announcement said.
“We are collaborating with ICMR-approved labs to help inthe quick scaling up of COVID-19 testing in India, a basic measure to check the spread of the infection in the nation,” Medlife prime supporter and CEO Ananth Narayanan said.
As the organization has its impact in the country’s battle against the pandemic, it is resolved to guarantee that standard and ceaseless patients keep on getting quality social insurance administrations, he included.
“The dispatch of our e-interview administration is planned for empowering helpless and in danger patients, particularly ones with incessant ailments, to guide their interests to our exceptionally prepared specialists from the security and solace of their homes”, Narayanan said.
The labs with which the organization has banded together are licensed by National Accreditation Board for Testing and Calibration Laboratories (NABL), a constituent leading group of the Quality Council of India.